Stringency sets how selectively the probe-target pairing is retained during processing. Temperature, salt concentration, and washing conditions are controlled together, and their combined effect determines signal specificity. Careful control helps researchers interpret detected labeling as evidence of the intended complementary sequence rather than an ambiguous signal, which is especially important when comparing targets across brain tissue.
Denaturation separates tissue nucleic-acid strands so the added probe can access a complementary target. The probe’s label then makes the pairing detectable after annealing and washing. This links molecular recognition to an observable signal, allowing the procedure to identify cellular targets and support measurements of gene expression in neural tissue.
Complementarity provides the sequence-level basis for assigning a signal to a particular nucleic-acid target. In practice, this selectivity allows investigators to examine where a chosen mRNA occurs and to compare its distribution among brain regions or cell populations, rather than treating all nucleic acids as equivalent.
A typical workflow begins by denaturing nucleic acids in prepared tissue, followed by applying a labeled probe. The probe is allowed to anneal under controlled temperature and salt conditions, and washing conditions are then used as part of the specificity control. The resulting label provides the detectable basis for locating the target.
By examining mRNA distribution directly within brain regions, in situ hybridization connects gene-expression signals with anatomical location. It can also help distinguish neuronal and glial populations, making the method useful for relating molecular targets to cellular organization, neural circuits, and changes associated with development or disease.
Its applications include mapping mRNA across brain regions, identifying cellular targets, and measuring gene-expression changes. Those readouts can be used to investigate development, neural circuits, and disease-related molecular changes. The approach is therefore suited to questions that require both a specific nucleic-acid target and information about where that target appears in nervous tissue.